Patología Molecular del Cáncer

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Gayarre J, Kamieniak MM, Cazorla-Jiménez A, Muñoz-Repeto I, Borrego S, García-Donas J, Hernando S, Robles-Díaz L, García-Bueno JM, Cajal TR, Hernández-Agudo E, Soto VH, Márquez-Rodas I, Echarri MJ, Lacambra-Calvet C, Sáez R, Cusidó M, Redondo A, Paz-Ares L, Hardisson D, Mendiola M, Palacios J, Benítez J, García MJ.

    The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients

    JOURNAL OF GYNECOLOGIC ONCOLOGY . 27(1): . Nº de citas: 13

    [doi:10.3802/jgo.2016.27.e7]

  • Miguel-Gomez L, Turrion-Merino L, Reguero-Calleja ME, Muñoz-Zato E.

    Subungual Keratoacanthoma

    Indian journal of dermatology . 60(6): 623-624.

    [doi:10.4103/0019-5154.169148]

  • Romero-Pérez L, Garcia-Sanz P, Mota A, Leskelä S, Hergueta-Redondo M, Díaz-Martín J, López-García MA, Castilla MA, Martínez-Ramírez A, Soslow RA, Matias-Guiu X, Moreno-Bueno G, Palacios J.

    A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc . 28(11): 1492-1503. Nº de citas: 17

    [doi:10.1038/modpathol.2015.102]

  • Diaz-Martin, Juan, Angeles Lopez-Garcia, Maria, Romero-Perez, Laura, Reina Atienza-Amores, Maria, Luisa Pecero, Maria, Angeles Castilla, Maria, Biscuola, Michele, Santon, Almudena, Palacios, Jose.

    Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer

    ENDOCRINE-RELATED CANCER . 22(3): 443-454. Nº de citas: 48

    [doi:10.1530/ERC-14-0456]

  • Calvete O, Reyes J, Zuñiga S, Paumard-Hernández B, Fernández V, Bujanda L, Rodriguez-Pinilla MS, Palacios J, Heine-Suñer D, Banka S, Newman WG, Cañamero M, Pritchard DM, Benítez J.

    Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastric neuroendocrine tumour

    HUMAN MOLECULAR GENETICS . 24(10): 2914-2922. Nº de citas: 48

    [doi:10.1093/hmg/ddv054]

  • Leskela S, Serrano A, de la Fuente H, Rodríguez-Muñoz A, Ramos-Levi A, Sampedro-Nuñez M, Sánchez-Madrid F, González-Amaro R, Marazuela M.

    Graves' Disease Is Associated with a Defective Expression of the Immune Regulatory Molecule Galectin-9 in Antigen-Presenting Dendritic Cells

    Plos One . 10(4): . Nº de citas: 13

    [doi:10.1371/journal.pone.0123938]

  • Alonso-Alconada L, Santacana M, Garcia-Sanz P, Muinelo-Romay L, Colas E, Mirantes C, Monge M, Cueva J, Oliva E, Soslow RA, Lopez MA, Palacios J, Prat J, Valls J, Krakstad C, Salvesen H, Gil-Moreno A, Lopez-Lopez R, Dolcet X, Moreno-Bueno G, Reventos J, Matias-Guiu X, Abal M.

    Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    INTERNATIONAL JOURNAL OF CANCER . 136(8): 1863-1873. Nº de citas: 29

    [doi:10.1002/ijc.29213]

  • Diaz-Lopez, Antonio, Diaz-Martin, Juan, Moreno-Bueno, Gema, Cuevas, Eva P., Santos, Vanesa, Olmeda, David, Portillo, Francisco, Palacios, Jose, Cano, Amparo.

    Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMT

    INTERNATIONAL JOURNAL OF CANCER . 136(4): 62-73. Nº de citas: 48

    [doi:10.1002/ijc.29177]

  • Kamieniak MM, Rico D, Milne RL, Muñoz-Repeto I, Ibáñez K, Grillo MA, Domingo S, Borrego S, Cazorla A, García-Bueno JM, Hernando S, García-Donas J, Hernández-Agudo E, Y Cajal TR, Robles-Díaz L, Márquez-Rodas I, Cusidó M, Sáez R, Lacambra-Calvet C, Osorio A, Urioste M, Cigudosa JC, Paz-Ares L, Palacios J, Benítez J, García MJ.

    Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients

    MOLECULAR ONCOLOGY . 9(2): 422-436. Nº de citas: 13

    [doi:10.1016/j.molonc.2014.09.010]

  • López-Calderero I, Carnero A, Astudillo A, Palacios J, Chaves M, Benavent M, Limón ML, Garcia-Carbonero R.

    Prognostic relevance of estrogen receptor-alpha Ser167 phosphorylation in stage II-III colon cancer patients

    HUMAN PATHOLOGY . 45(12): 2437-2446. Nº de citas: 9

    [doi:10.1016/j.humpath.2014.08.008]

  • Santacana M, Maiques O, Valls J, Gatius S, Abó AI, López-García MÁ, Mota A, Reventós J, Moreno-Bueno G, Palacios J, Bartosch C, Dolcet X, Matias-Guiu X.

    A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry

    HUMAN PATHOLOGY . 45(12): 2394-2403. Nº de citas: 10

    [doi:10.1016/j.humpath.2014.06.031]

  • Castilla MÁ, López-García MÁ, Atienza MR, Rosa-Rosa JM, Díaz-Martín J, Pecero ML, Vieites B, Romero-Pérez L, Benítez J, Calcabrini A, Palacios J.

    VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer

    ENDOCRINE-RELATED CANCER . 21(4): 587-599. Nº de citas: 42

    [doi:10.1530/ERC-13-0485]

  • Melchor L, Molyneux G, Mackay A, Magnay FA, Atienza M, Kendrick H, Nava-Rodrigues D, López-García MÁ, Milanezi F, Greenow K, Robertson D, Palacios J, Reis-Filho JS, Smalley MJ.

    Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models

    JOURNAL OF PATHOLOGY . 233(2): 124-137. Nº de citas: 33

    [doi:10.1002/path.4345]

  • Molina-Pinelo S, Gutiérrez G, Pastor MD, Hergueta M, Moreno-Bueno G, García-Carbonero R, Nogal A, Suárez R, Salinas A, Pozo-Rodríguez F, Lopez-Rios F, Agulló-Ortuño MT, Ferrer I, Perpiñá A, Palacios J, Carnero A, Paz-Ares L.

    MicroRNA-Dependent Regulation of Transcription in Non-Small Cell Lung Cancer

    Plos One . 9(3): . Nº de citas: 57

    [doi:10.1371/journal.pone.0090524]

  • Gutierrez-Pecharroman A, Tirado-Zambrana P, Pascual A, Rubio-Marin D, García-Cosío M, Moratalla-Bartolomé E, Palacios J.

    A Uterine Tumor Resembling Ovarian Sex Cord Tumor Associated With Tamoxifen Treatment: A Case Report and Literature Review

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY . 33(2): 151-155. Nº de citas: 3

    [doi:10.1097/PGP.0b013e318286b4d9]

  • Díaz-Martín J, Díaz-López A, Moreno-Bueno G, Castilla MÁ, Rosa-Rosa JM, Cano A, Palacios J.

    A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition

    JOURNAL OF PATHOLOGY . 232(3): 319-329. Nº de citas: 57

    [doi:10.1002/path.4289]

  • Romero-Pérez L, López-García MÁ, Díaz-Martín J, Biscuola M, Castilla MÁ, Tafe LJ, Garg K, Oliva E, Matias-Guiu X, Soslow RA, Palacios J.

    ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc . 26(11): 1514-1524. Nº de citas: 55

    [doi:10.1038/modpathol.2013.93]

  • Leandro-García LJ, Inglada-Pérez L, Pita G, Hjerpe E, Leskelä S, Jara C, Mielgo X, González-Neira A, Robledo M, Avall-Lundqvist E, Gréen H, Rodríguez-Antona C.

    Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy

    JOURNAL OF MEDICAL GENETICS . 50(9): 599-605. Nº de citas: 57

    [doi:10.1136/jmedgenet-2012-101466]